Skip to main content

Table 5 Iron Parameters

From: Incidence and predictors of iron deficiency anaemia in parturients undergoing elective caesarean section at a tertiary hospital in New Zealand: a retrospective, observational cohort study

 

Overall Cohort

Anaemia

HB < 110 g/L

No Anaemia

HB ≥110 g/L

p-value

Haemoglobin Recording Obtained

    

- 1st Trimester

302 (27.6%)

46 (27.4%)

217 (28.4%)

0.85

- 2nd Trimester

319 (29.2%)

59 (35.1%)

240 (31.4%)

0.36

- 3rd Trimester

556 (50.9%)

103 (61.3%)

453 (59.2%)

0.66

Ferritin Recording Obtained

    

- 1st Trimester

207 (18.9%)

30 (17.9%)

157 (20.5%)

0.46

- 2nd Trimester

224 (20.5%)

40 (23.8%)

177 (23.1%)

0.84

- 3rd Trimester

438 (40.1%)

74 (44.0%)

364 (47.6%)

0.44

Anaemia – < 110 g/L

    

- 1st Trimester

22 (7.3%)

11 (23.9%)

11 (5.1%)

- 2nd Trimester

97 (30.4%)

35 (59.3%)

57 (23.8%)

- 3rd Trimester

190 (34.2%)

95 (92.2%)

95 (21.0%)

Iron Therapy Pre-Operatively

    

- No Iron

426 (39.0%)

69 (41.1%)

289 (37.8%)

0.43

- Oral Iron

630 (57.6%)

84 (50.0%)

456 (59.6%)

0.03

- Intravenous Iron

64 (5.9%)

26 (15.5%)

34 (4.4%)

< 0.001

Thresholds for IV Iron Therapy

    

- HB < 110 g/L and Ferritin < 20 mcg/L

71 (6.5%)

71 (42.3%)

0 (0.0%)

- HB < 110 g/L and Ferritin <30 mcg/L

83 (7.6%)

83 (49.4%)

0 (0.0%)

- HB < 120 g/L and Ferritin < 20 mcg/L

158 (14.5%)

71 (42.3%)

87 (11.4%)

- HB < 120 g/L and Ferritin <30 mcg/L

198 (18.1%)

83 (49.4%)

115 (15.0%)

  1. This table shows the number of HB and ferritin recordings obtained for the overall cohort of patients in each trimester. Comparison columns between the number of blood tests obtained in the anaemic and non-anaemic groups. The number of patients who had documented oral and iv iron therapy in each group is shown in the fourth row. The final row shows the effect of using different thresholds for IV iron therapy based on the HB and ferritin levels recorded. For example, if a more liberal threshold of HB < 120 g/L and Ferritin <30 mcg/L were to be used, a greater proportion (49.4%) of the anaemic cohort would receive IV iron when compared to a stricter threshold of HB < 110 g/L and Ferritin < 20 mcg/L.
  2. 3rd trimester data presented from 27 weeks until 2 weeks prior to delivery to allow time for any potential intervention to have an effect
  3. Data presented as number (percent) or median (interquartile range) as appropriate
  4. Sidak correction for multiple tests – revised p-value for statistical significance becomes 0.017 – significant results highlighted in bold